page_banner

Products

n-(triphenylmethyl)-5-(4′-bromomethylbiphenyl-2-yl-)terazole CAS:124750-51-2

Short Description:

Catalog Number: XD96277
Cas: 124750-51-2
Molecular Formula: C33H25BrN4
Molecular Weight: 557.48
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD96277
Product Name n-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole
CAS 124750-51-2
Molecular Formula C33H25BrN4
Molecular Weight 557.48
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole is a chemical compound with potential therapeutic effects that falls into the category of terazoles. While specific research on this compound is limited, we can discuss the potential effects and implications based on the properties of similar compounds within the terazole family.Terazoles are a class of compounds that have shown promising effects in various therapeutic applications. One potential effect of N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole is its ability to act as an antifungal agent. Terazoles have been extensively studied for their antifungal properties, particularly against yeast and fungal infections. They act by inhibiting the production of ergosterol, a key component of fungal cell membranes, leading to the disruption of their cellular integrity and eventual death. While more specific research is needed to determine the antifungal potency of this compound, it is possible that N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole may exhibit similar effects against fungal infections.Furthermore, terazoles have also demonstrated potential applications as antitumor agents. Some terazole derivatives have shown inhibitory effects on the growth and proliferation of cancer cells. These compounds can interfere with the DNA replication and cell division processes, leading to cell cycle arrest and apoptosis in cancer cells. Although more research is required to evaluate the antitumor potential of N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole specifically, it is possible that it may possess similar effects against certain types of cancer.Additionally, terazoles have been investigated for their role as anti-inflammatory agents. Some studies have shown that these compounds can inhibit the production of pro-inflammatory molecules and modulate the immune response, resulting in potential anti-inflammatory effects. While specific research on the anti-inflammatory potency of N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole is lacking, it is plausible that it may possess similar properties.It is crucial to note that the potential effects discussed above are based on the general properties and activities of terazole derivatives. Further research is necessary to fully comprehend the specific pharmacological effects, safety profile, and potential therapeutic applications of N-(triphenylmethyl)-5-(4'-bromomethylbiphenyl-2-yl-)terazole. Additionally, factors such as the compound's solubility, stability, and bioavailability will play a significant role in determining its pharmaceutical efficacy.


  • Previous:
  • Next:

  • Close

    n-(triphenylmethyl)-5-(4′-bromomethylbiphenyl-2-yl-)terazole CAS:124750-51-2